India's identity as the "generic pharmacy of the world," rather than the overall "pharmacy of the world," is attributed to a pervasive culture of fear in its entrepreneurial ecosystem. This fear stifles the risk-taking necessary for breakthrough innovation.
A speaker directly challenges the common narrative that China's dominance has destroyed India's Active Pharmaceutical Ingredient (API) sector. This suggests Indian API manufacturing remains a competitive and viable industry, despite widespread reports to the contrary.